Abstract LB238: Expanding the TEAD therapeutic potential with degraders: In vitro sensitivity, predictive biomarkers, and in vivo efficacy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Rajiv Sawant, Matthis Geitmann, Thomas Gossas, Wei B. Emond, Ulf Bremberg, Konrad Koehler, Melissa M. Ronan, Matthew G. Rees, Jennifer A. Roth, Peter Brandt
Institutions: Beactica (Sweden), Broad Institute
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409820701